MIR6765

Across TCGA pan-cancer cohorts, MIR6765 RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated MIR6765 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher MIR6765 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR6765 expression acts as an unfavorable survival marker, although some lineages such as OV show a favorable association.

ACC, SARC, and OV are the cancer types where MIR6765 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Tertile	All	0.010	0.624	<.001	81	view →
SARC	OS	Tertile	All	0.343	0.786	<.001	27	view →
OV	DFS	Tertile	All	1.000	0.156	.039	24	view →
UVM	OS	Tertile	All	0.249	0.712	.033	18	view →
BLCA	OS	Tertile	III,IV	0.208	0.581	.022	18	view →
HNSC	DFS	Tertile	III,IV	0.380	0.624	.038	18	view →
LGG	DFS	Tertile	All	0.137	0.421	.012	15	view →
PAAD	DFS	Tertile	All	0.231	0.514	.039	9	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

MIR6765–ACC (DFS)

Open the ACC breakdown →